Currently the price is 6,44$, In this post we are going to talk about the listed company Replimune Group Inc, its leaders are Colin A. Love (Chief Operating Officer), Jean M. Franchi (Chief Financial Officer, Secretary & Treasurer), Pamela Esposito (Chief Business Officer), Philip Astley-Sparke (Chief Executive Officer & Director), Robert Coffin (President & Director), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 6,67$ moving between 6,41$ and 6,92$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
